Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|September 29, 2015
TIGIT predominantly regulates the immune response via regulatory T cellsSema Kurtulus, Kaori Sakuishi, Shin-Foong Ngiow, et al.
European Journal of Immunology|July 11, 2012
Both IFN-γ and IL-17 are required for the development of severe autoimmune gastritisEric Tu, Desmond K Y Ang, Shayne A Bellingham, et al.
Cancer Research|March 25, 2010
Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletionMichele W L Teng, Jeremy B Swann, Bianca von Scheidt, et al.
Trials|December 21, 2019
Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)Elizabeth Ahern, Annette Cubitt, Emma Ballard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasisMichele W L Teng, Daniel M Andrews, Nicole McLaughlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulationNicole M Haynes, Joseph A Trapani, Michele W L Teng, et al.
Blood|October 18, 2002
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumorsNicole M Haynes, Joseph A Trapani, Michèle W L Teng, et al.
Oncoimmunology|May 4, 2018
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activityAmelia Roman Aguilera, Viviana P Lutzky, Deepak Mittal, et al.
Cancer Gene Therapy|March 3, 2007
Antitumor activity of dual-specific T cells and influenza virusA Murphy, J A Westwood, L E Brown, et al.
Cancer Research|August 10, 2016
Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of CancerJing Liu, Stephen J Blake, Heidi Harjunpää, et al.
Pageof 11